No Data
No Data
Wells Fargo Downgrades United Therapeutics(UTHR.US) to Hold Rating, Cuts Target Price to $314
This United Therapeutics Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday
United Therapeutics Price Target Cut to $314.00/Share From $395.00 by Wells Fargo
United Therapeutics Cut to Equal-Weight From Overweight by Wells Fargo
Earnings Preview: UTHR to Report Financial Results Pre-market on April 30
BofA Securities Upgrades United Therapeutics(UTHR.US) to Hold Rating, Cuts Target Price to $314